The Elderly in Drug Research
Towards Active and Healthy Ageing
DOI:
https://doi.org/10.14422/rib.i12.y2020.007Keywords:
healthy ageing, clinical research, health policiesAbstract
Recent decades have seen a progressive ageing of the population that is drawing the attention of institutions worldwide in order to promote healthy ageing. Chronic diseases are part of ageing and the geriatric population is the largest consumer of drugs. Limiting the participation of this population in clinical research may result in a lack of information on drug safety and efficiency. It is necessary to take actions that include clinical research as part of healthy ageing as it promotes active ageing and provides relevant information for better use of medicines within this sector of the population.
Downloads
References
Alvino, S. (2014). Elderly Representation in Clinical Trials: Not a grey area. inVentive Health White Paper. April 2014. https://www.clinicalleader.com/doc/elderly-representation-in-clinical-trials-not-a-gray-area-0001 a fecha 7 de febrero de 2020.
Beard, J., & Bloom, D. (2015). Towards a comprehensive public health response to population aging. Lancet, 358(9968), 658-661. DOI: https://doi.org/10.1016/S0140-6736(14)61461-6
Cerreta, F., Eichler, H. G., & Rasi, G. (2012). Drug Policy for an Aging Population — The European Medicines. Agency’s Geriatric Medicines Strategy. New England Journal Medicine, (367), 1972-1974. DOI: https://doi.org/10.1056/NEJMp1209034
Convenio Europeo de Derechos Humanos. Modificado por los Protocolos nos. 11 y 14 completado por el Protocolo adicional y los Protocolos nos. 4, 6, 7, 12, 13 y 16. European court of human rights. Council of Europe.
Gu, Q., Dillon, C. F., & Burt, V. L. (2010). Prescription Drug Use Continues to Increase: U.S. Prescription Drug Data for 2007-2008. NCHS data brief, 42(42), 1-8.
Healthy ageing. A challenge for Europe. The Healthy ageing project is Co-Funded by the European Commission. The Swedish National Institute of Public Health.
OMS. (2002). Envejecimiento activo: un marco político. Revista española de geriatría y gerontología, 37(S2), 74-105.
OMS. (2015). Informe mundial sobre el envejecimiento y salud. Organización Mundial de la Salud.
ONU. (2002). Declaración Política y Plan de Acción Internacional de Madrid sobre el envejecimiento. Nueva York: Naciones Unidas 2002. Revista española de geriatría y gerontología, 37(S2), 12-36.
Studies in Support of Special Populations (E7) (2010). Geriatrics Questions & Answers. International Conference on Harmonization of Technical Requirements for registration of pharmaceuticals for human use ICH Secretariat. Geneva: ICH Secretariat.
Warren Kaplan, R. L. (2004). Priority Medicines for Europe and the World. World Health November 2004. World Health Organization. Department of Essential Drugs and Medicines Policy
World Population Prospects. (2019). Highlights. United Nations, Department of Economic and Social Affairs, Population Division. New York: United Nations.
Xia S., Zhang, X., Zheng, S., Khanabdali, R., Kalionis, B., Wu, J., Wan, W., & Tai, X. (2016). An Update on Inflamm-Aging: Mechanisms, Prevention, and Treatment. J Immunol Research, Article ID: 8426874. DOI: https://doi.org/10.1155/2016/8426874
Downloads
Published
How to Cite
Issue
Section
License
The authors of articles published in Revista Iberoamericana de Bioética retain the intellectual property rights over their works and grant the journal their distribution and public communication rights, consenting to their publication under a Creative Commons Attribution-NonCommercial-NoDerivates 4.0 Internacional. Authors are encouraged to publish their work on the Internet (for example, on institutional or personal pages, repositories, etc.) respecting the conditions of this license and quoting appropriately the original source.
